NOMAD POWER SOLUTIONS, INC. Net Income (Loss) Available to Common Stockholders, Basic
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Net Income (Loss) Available to Common Stockholders, Basic of -$2.19 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2026-08-14
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-06-30 was -$2.19M.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2026-03-31 was -$1.94M.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-09-30 was -$2.03M.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for the quarter ending 2025-06-30 was -$775.67K.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for fiscal 2016 was -$2.13M.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for fiscal 2015 was -$2.85M.
- NOMAD POWER SOLUTIONS, INC. net income (loss) available to common stockholders, basic for fiscal 2014 was -$2.77M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.19M 10-Q · filed 2026-08-14 | -$4.13M 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$1.94M 10-Q · filed 2026-05-14 | |||
| 2025-09-30 | -$2.03M 10-Q · filed 2025-11-12 | -$2.81M derived: sum of 2 quarters · filed 2026-08-14 | -$3.52M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | -$775.67K 10-Q · filed 2026-08-14 | -$1.49M 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$709.55K 10-Q · filed 2026-05-14 | |||
| 2024-09-30 | -$986.03K 10-Q · filed 2025-11-12 | -$2.97M 10-Q · filed 2025-11-12 | ||
| 2016-12-31 | -$516.26K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$1.16M derived: sum of 2 quarters · filed 2017-03-29 | -$1.72M derived: sum of 3 quarters · filed 2017-03-29 | -$2.13M 10-K · filed 2017-03-29 |
| 2016-09-30 | -$646.94K 10-Q · filed 2016-11-04 | -$1.20M derived: sum of 2 quarters · filed 2016-11-04 | -$1.62M 10-Q · filed 2016-11-04 | -$2.23M derived: sum of 4 quarters · filed 2017-03-29 |
| 2016-06-30 | -$555.00K 10-Q · filed 2016-08-10 | -$971.54K 10-Q · filed 2016-08-10 | -$1.59M derived: sum of 3 quarters · filed 2017-03-29 | -$2.37M derived: sum of 4 quarters · filed 2017-03-29 |
| 2016-03-31 | -$416.54K 10-Q · filed 2016-05-06 | -$1.03M derived: sum of 2 quarters · filed 2017-03-29 | -$1.81M derived: sum of 3 quarters · filed 2017-03-29 | -$2.31M derived: sum of 4 quarters · filed 2017-03-29 |
| 2015-12-31 | -$615.85K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-29 | -$1.40M derived: sum of 2 quarters · filed 2017-03-29 | -$1.90M derived: sum of 3 quarters · filed 2017-03-29 | -$2.85M 10-K · filed 2017-03-29 |
| 2015-09-30 | -$779.69K 10-Q · filed 2016-11-04 | -$1.28M derived: sum of 2 quarters · filed 2016-11-04 | -$2.24M 10-Q · filed 2016-11-04 | |
| 2015-06-30 | -$500.65K 10-Q · filed 2016-08-10 | -$1.46M 10-Q · filed 2016-08-10 | ||
| 2015-03-31 | -$957.92K 10-Q · filed 2016-05-06 | |||
| 2014-12-31 | -$2.77M 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |